Cost-effectiveness of the sustained-release paclitaxel-eluting Eluvia stent compared to the paclitaxel-coated Zilver PTX stent for endovascular treatment of peripheral artery disease – a German Statutory Sickness Fund perspective

Authors:

Giretti C, Gray W, Elroy P, Akehurst R, Amorosi S, Griffiths R and Müller-Hülsbeck S.

Publication type:

Conference Proceedings – Poster

Publication Name:

ISPOR Europe 2019

Citation:

Giretti C, Gray W, Elroy P, Akehurst R, Amorosi S, Griffiths R and Müller-Hülsbeck S. Cost-effectiveness of the sustained-release paclitaxel-eluting Eluvia stent compared to the paclitaxel-coated Zilver PTX stent for endovascular treatment of peripheral artery disease – a German Statutory Sickness Fund perspective. 19th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress. Copenhagen, Denmark. 2-6 November 2019. PCV56.

Link to publication ⟶

⟵ Back to Search Results